Search Results
Results found for "Owen P. McGuinness"
- Exploring the Breakthroughs in GPCR Research
Early-bird registration for premium Ecosystem members opens on July 31st, so mark your calendars and
- 📰 GPCR Weekly News, December 4 to 10, 2023
Registrations open on December 15th and close on February 1st to both Dr.
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
This dual role opens new possibilities for more complex and nuanced cellular responses.
- How to Avoid the Most Common Gaps in Your Biotech Pitch
. 👉 Opening with mechanisms forces the listener to do all the work. building for, why now is the right time, and how your solution fits into something bigger than your own
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
For discovery teams, this means a shorter exposure can yield longer efficacy windows—opening doors to can fail quietly at this stage —not because they’re weak, but because they’re too strong for their own Tissue Penetration Trap Here’s a paradox: high-affinity, slow-offset compounds can undermine their own Kenakin with your own enzyme or GPCR interaction puzzles.
- Advantages of Fluorescent Probes in GPCR Assays
However, over half of non-sensory GPCRs do not have drugs available in the clinic, opening the door to
- 📰 GPCR Weekly News, January 8 to 14, 2024
Registrations are open to everyone (you will need to become a free site member) and end on February 1st
- 📰 GPCR Weekly News, April 10 to 16, 2023
Now you can submit your job opening and offer a position in an exclusive GPCR community around the globe
- 📰 GPCR Weekly News, January 1 to 7, 2024
Registrations are open to everyone (you will need to become a free site member) and end on February 1st
- 📰 GPCR Weekly News, June 26 to July 2, 2023
Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Retreat (November 2 - 4, 2023) Registration is now open
- 📰 GPCR Weekly News, April 22 to 28, 2024
Team Registrations are also open! You have until 5 pm EST tomorrow to register.
- GPCR Buzz of the Week | Sep 23 - 29, 2024
Registration is open for our November class .
- 📰 GPCR Weekly News, January 22 to 28, 2024
If you're still keen on joining this course but missed out on registration, don't worry; we've opened
- 📰 GPCR Weekly News, July 1 to 7, 2024
Mark your calendars because registration opens on July 18, 2024!
- 📰 GPCR Weekly News, December 18 to 31, 2023
Registrations are open to Dr. GPCR Ecosystem Members!
- From Failed Experiments to Predictive GPCR Models
For Carlsson, influential mentors helped him find confidence in his own scientific voice while remaining open to other perspectives. Modeling a Career on Your Own Terms Carlsson’s career shows that failures can evolve into strengths and
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
Kenakin live for an open Q&A session designed for discovery scientists. Kenakin with your own enzyme or GPCR interaction puzzles.
- 📰 GPCR Weekly News, May 13 to 19, 2024
Stay tuned for further details, as we plan to open registrations for both courses in July 2024. Dr. Our most recent episode features our very own Dr. GPCR Board. Tune in and enjoy! Dr.
- The Real Cost of Strategic Overload in Biotech
A platform application opens a larger market. A grant opportunity aligns with ongoing research. optional exploration 👉 The perceived execution risk increases None of these issues is dramatic on its own
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
World first: Australian scientists uncover “plant-like” behavior in important human cell regulator, opening
- 📰 GPCR Weekly News, February 19 to 25, 2024
By being on the waitlist, you’ll be the first to be notified when official registrations open for the
- 📰 GPCR Weekly News, January 29 to February 4, 2024
you'll be the first notified, and you'll be able to register for the course official registrations open
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
in GPCR Signaling and its Implication in Drug Development: A One-Sided Affair Agonist activation to open
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
One more indication to keep options open. One more discussion before committing. None of these choices looks wrong on its own. 👉 This is how biotech startup failure often begins , not justified as prudent Busy teams without a shared directional anchor None of these raises alarms on their own No one decision owns the outcome. No single leader feels accountable for the trajectory.
- How Early Strategic Decision Making Creates Alignment and Better Results
What if the real leverage was never in the metrics but in the choices made when everything still felt open
- Targeting Intracellular Allosteric Sites in GPCRs
focused on orthosteric sites, but recent breakthroughs in understanding allosteric modulation have opened
- Structural landscape of the Chemokine Receptor system
to diverse activation mechanisms that converge at the transducer coupling region, resulting in the opening















